This is good news given risks of systemic side-effects when infused, including cytokine storm and multiple organ failure incl. hepatoxicity.
There is a critical shortage of classes of antimycotics. For example, 3 medications of the echinocandin class remain useful in treating multi-drug resistant c. auris, the beastie that sometimes requires throwing out durable hospital equipment and tearing out the walls due to contamination.
There is a critical shortage of classes of antimycotics. For example, 3 medications of the echinocandin class remain useful in treating multi-drug resistant c. auris, the beastie that sometimes requires throwing out durable hospital equipment and tearing out the walls due to contamination.
https://slate.com/technology/2019/04/candida-auris-hospitals...